{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:44:51Z","timestamp":1781898291236,"version":"3.54.5"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmech.2025.117899","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T11:01:57Z","timestamp":1750849317000},"page":"117899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rational optimization of D3R\/GSK-3\u03b2 dual target-directed ligands as potential treatment for bipolar disorder: Design, synthesis, X-ray crystallography, molecular dynamics simulations, in vitro ADME, and in vivo pharmacokinetic studies"],"prefix":"10.1016","volume":"297","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2287-3331","authenticated-orcid":false,"given":"R.M.C.","family":"Di Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Demuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dalle Vedove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Spagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ottonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Bertozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Summa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Desantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Valeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pruccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tarozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Storici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Girotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bertorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Armirotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cruciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bandiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bottegoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2025.117899_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117899_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41398-020-01146-0","article-title":"Clinical and genetic differences between bipolar disorder type 1 and 2 in multiplex families","volume":"11","author":"Guzman-Parra","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117899_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41380-021-01091-4","article-title":"A unified model of the pathophysiology of bipolar disorder","volume":"27","author":"Magioncalda","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117899_bib4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mp.2017.16","article-title":"The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment","volume":"22","author":"Ashok","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117899_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/1389200219666171227203737","article-title":"Glycogen synthase Kinase-3\u03b2 as a putative therapeutic target for bipolar disorder","volume":"19","author":"Dandekar","year":"2018","journal-title":"Curr. Drug Metab."},{"issue":"22","key":"10.1016\/j.ejmech.2025.117899_bib6","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1021\/acs.jmedchem.5b01208","article-title":"Hit optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: potent glycogen synthase Kinase-3 (GSK-3) inhibitors with in vivo activity in model of mood disorders","volume":"58","author":"Furlotti","year":"2015","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117899_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1021\/acsmedchemlett.9b00633","article-title":"Optimization of indazole-based GSK-3 inhibitors with mitigated hERG issue and in vivo activity in a mood disorder model","volume":"11","author":"Prati","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117899_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.73","article-title":"Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor \u03b2-arrestin interactions","volume":"3","author":"Gao","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117899_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","article-title":"The Akt-GSK-3 signaling Cascade in the actions of dopamine","volume":"28","author":"Beaulieu","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"issue":"36","key":"10.1016\/j.ejmech.2025.117899_bib10","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.0803522105","article-title":"Antagonism of dopamine D2 receptor\/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics","volume":"105","author":"Masri","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117899_bib11","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s40265-019-01189-8","article-title":"Dopamine receptor partial agonists for the treatment of bipolar disorder","volume":"79","author":"Azorin","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.117899_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fpsyt.2020.00377","article-title":"Lithium treatment over the lifespan in bipolar disorders","volume":"11","author":"Volkmann","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117899_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/bdi.12375","article-title":"The lithium battery: assessing the neurocognitive profile of lithium in bipolar disorder","volume":"18","author":"Malhi","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ejmech.2025.117899_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117899_bib15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/S1092852917000608","article-title":"Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes","volume":"22","author":"Stahl","year":"2017","journal-title":"CNS Spectr."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117899_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/13543776.2022.2049240","article-title":"Dopamine D3 receptor ligands: a patent review (2014-2020)","volume":"32","author":"Di Martino","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117899_bib17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuint.2011.07.002","article-title":"Cariprazine (RGH-188), a potent D3\/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents","volume":"59","author":"Gyerty\u00e1n","year":"2011","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117899_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.64719\/pb.4374","article-title":"Cariprazine to treat schizophrenia and bipolar disorder in adults","volume":"50","author":"Edinoff","year":"2020","journal-title":"Psychopharmacol. Bull."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117899_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1017\/S109285291900083X","article-title":"The role of dopamine D(3) receptors in the mechanism of action of cariprazine","volume":"25","author":"Calabrese","year":"2020","journal-title":"CNS Spectr."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117899_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2022-100760","article-title":"Bipolar depression: a review of treatment options","volume":"35","author":"Levenberg","year":"2022","journal-title":"Gen. Psychiatr."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117899_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/jtbi.1996.0130","article-title":"Rational design of receptor partial agonists and possible mechanisms of receptor partial activation: a theory","volume":"181","author":"Zhu","year":"1996","journal-title":"J. Theor. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117899_bib22","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1021\/acs.jmedchem.2c01624","article-title":"Dopamine D3\/D2 receptor ligands based on cariprazine for the treatment of psychostimulant use disorders that may be dual diagnosed with affective disorders","volume":"66","author":"Gogarnoiu","year":"2023","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117899_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/acsmedchemlett.9b00039","article-title":"Harnessing polypharmacology with medicinal chemistry","volume":"10","author":"Bolognesi","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117899_bib24","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/cmdc.201600161","article-title":"Multitarget drug discovery and polypharmacology","volume":"11","author":"Bolognesi","year":"2016","journal-title":"ChemMedChem"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117899_bib25","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1021\/acs.jmedchem.4c00838","article-title":"Systematic investigation of dual-target-directed ligands","volume":"67","author":"Lembo","year":"2024","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117899_bib26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/cmdc.202000210","article-title":"Multitarget compounds for bipolar disorder: from rational design to preliminary pharmacokinetic evaluation","volume":"15","author":"Di Martino","year":"2020","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117899_bib27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/jm049465g","article-title":"Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor","volume":"48","author":"Grundt","year":"2005","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2025.117899_bib28","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0960-894X(03)00389-5","article-title":"N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists","volume":"13","author":"Newman","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6742","key":"10.1016\/j.ejmech.2025.117899_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/22560","article-title":"Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist","volume":"400","author":"Pilla","year":"1999","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117899_bib30","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1021\/jm000090i","article-title":"Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): a potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat","volume":"43","author":"Stemp","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117899_bib31","series-title":"Carboxyamido Derivatives","author":"Ando","year":"2001"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117899_bib32","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/cmdc.201500521","article-title":"Development and application of a virtual screening protocol for the identification of multitarget fragments","volume":"11","author":"Bottegoni","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.117899_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111975","article-title":"Multi-target dopamine D3 receptor modulators: actionable knowledge for drug design from molecular dynamics and machine learning","volume":"188","author":"Ferraro","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117899_bib34","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1021\/acs.jmedchem.3c00417","article-title":"Pharmacological and physicochemical properties optimization for dual-target dopamine D(3) (D(3)R) and \u03bc-Opioid (MOR) receptor ligands as potentially safer analgesics","volume":"66","author":"Bonifazi","year":"2023","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117899_bib35","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1021\/acs.jmedchem.1c00611","article-title":"Novel dual-target \u03bc-Opioid receptor and dopamine D(3) receptor ligands as potential nonaddictive pharmacotherapeutics for pain management","volume":"64","author":"Bonifazi","year":"2021","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117899_bib36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1021\/acschemneuro.6b00029","article-title":"Central nervous system multiparameter optimization desirability: application in drug discovery","volume":"7","author":"Wager","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117899_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.576559","article-title":"P-Glycoprotein: one mechanism, many tasks and the consequences for pharmacotherapy of cancers","volume":"10","author":"Seelig","year":"2020","journal-title":"Front. Oncol."},{"issue":"24","key":"10.1016\/j.ejmech.2025.117899_bib38","doi-asserted-by":"crossref","first-page":"16615","DOI":"10.1021\/acs.jmedchem.3c01069","article-title":"Modeling substrate entry into the P-Glycoprotein efflux pump at the blood\u2013brain barrier","volume":"66","author":"Jorgensen","year":"2023","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2025.117899_bib39","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1021\/jm400856t","article-title":"Polypharmacology \u2013 Foe or friend?","volume":"56","author":"Peters","year":"2013","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2025.117899_bib40","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117899_bib41","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acs.jmedchem.6b01578","article-title":"Design, synthesis, structure-activity relationship studies, and three-dimensional quantitative structure-activity relationship (3D-QSAR) modeling of a series of O-Biphenyl carbamates as dual modulators of dopamine D3 receptor and fatty acid amide hydrolase","volume":"60","author":"De Simone","year":"2017","journal-title":"J. Med. Chem."},{"issue":"38","key":"10.1016\/j.ejmech.2025.117899_bib42","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1039\/C4CC00967C","article-title":"Applying a multitarget rational drug design strategy: the first set of modulators with potent and balanced activity toward dopamine D3 receptor and fatty acid amide hydrolase","volume":"50","author":"De Simone","year":"2014","journal-title":"Chem. Commun."},{"issue":"22","key":"10.1016\/j.ejmech.2025.117899_bib43","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1021\/jm050529c","article-title":"MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist","volume":"48","author":"Cruciani","year":"2005","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117899_bib44","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/j.ddtec.2012.10.015","article-title":"High-throughput, computer assisted, specific MetID. A revolution for drug discovery","volume":"10","author":"Zamora","year":"2013","journal-title":"Drug Discov. Today Technol."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117899_bib45","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1021\/jm300482h","article-title":"Molecular determinants of selectivity and efficacy at the dopamine D3 receptor","volume":"55","author":"Newman","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117899_bib46","first-page":"211","article-title":"Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents","volume":"5","author":"Kirino","year":"2014","journal-title":"Adolesc. Health Med. Ther."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117899_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/026988110401800308","article-title":"Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile","volume":"18","author":"Hirose","year":"2004","journal-title":"J. Psychopharmacol."},{"issue":"24","key":"10.1016\/j.ejmech.2025.117899_bib48","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1073\/pnas.86.24.9762","article-title":"Cloning of the cDNA and gene for a human D2 dopamine receptor","volume":"86","author":"Grandy","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117899_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0922-4106(94)90212-7","article-title":"Characterization of the human dopamine D3 receptor expressed in transfected cell lines","volume":"266","author":"MacKenzie","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117899_bib50","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0022-3565(25)20674-7","article-title":"Characterization of two cloned human CB1 cannabinoid receptor isoforms","volume":"278","author":"Rinaldi-Carmona","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"17","key":"10.1016\/j.ejmech.2025.117899_bib51","doi-asserted-by":"crossref","first-page":"12954","DOI":"10.1016\/S0021-9258(18)99968-0","article-title":"Human 5-HT1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s)","volume":"269","author":"Mulheron","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117899_bib52","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0024-3205(96)00449-3","article-title":"A novel class of 5-HT2A receptor antagonists: aryl aminoguanidines","volume":"59","author":"Bryant","year":"1996","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117899_bib53","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00109-023-02373-w","article-title":"GSK-3\u03b1 aggravates inflammation, metabolic derangement, and cardiac injury post-ischemia\/reperfusion","volume":"101","author":"Ahmad","year":"2023","journal-title":"J. Mol. Med. (Berl)"},{"issue":"22","key":"10.1016\/j.ejmech.2025.117899_bib54","doi-asserted-by":"crossref","first-page":"8907","DOI":"10.1021\/acs.jmedchem.5b01200","article-title":"Evaluation of improved glycogen synthase Kinase-3\u03b1 inhibitors in models of acute myeloid leukemia","volume":"58","author":"Neumann","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117899_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115521","article-title":"Function and inhibition of DYRK1A: emerging roles of treating multiple human diseases","volume":"212","author":"Yang","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"731","key":"10.1016\/j.ejmech.2025.117899_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.add6883","article-title":"Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome","volume":"16","author":"Lana-Elola","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"10.1016\/j.ejmech.2025.117899_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22169098","article-title":"GSK-3\u03b2, FYN, and DYRK1A: master regulators in neurodegenerative pathways","volume":"22","author":"Demuro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117899_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118746","article-title":"Glycogen synthase kinase-3 signaling in cellular and behavioral responses to psychostimulant drugs","volume":"1867","author":"Barr","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"16","key":"10.1016\/j.ejmech.2025.117899_bib59","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1007\/s00213-014-3491-8","article-title":"Reactivation of cocaine reward memory engages the Akt\/GSK3\/mTOR signaling pathway and can be disrupted by GSK3 inhibition","volume":"231","author":"Shi","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117899_bib60","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(24)29270-3","article-title":"Rational use of in vitro P-glycoprotein assays in drug discovery","volume":"299","author":"Polli","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117899_bib61","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/antiox9060551","article-title":"Esculetin as a bifunctional antioxidant prevents and counteracts the oxidative stress and neuronal death induced by amyloid protein in SH-SY5Y cells","volume":"9","author":"Pruccoli","year":"2020","journal-title":"Antioxidants"},{"issue":"7","key":"10.1016\/j.ejmech.2025.117899_bib62","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117899_bib63","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2025.117899_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114054","article-title":"ARN25068, a versatile starting point towards triple GSK-3\u03b2\/FYN\/DYRK1A inhibitors to tackle tau-related neurological disorders","volume":"229","author":"Demuro","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"Pt 2","key":"10.1016\/j.ejmech.2025.117899_bib65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch","year":"2010","journal-title":"XDS. Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 7","key":"10.1016\/j.ejmech.2025.117899_bib66","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallagr."},{"issue":"Pt 10","key":"10.1016\/j.ejmech.2025.117899_bib67","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"issue":"Pt 4","key":"10.1016\/j.ejmech.2025.117899_bib68","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425006646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:48:26Z","timestamp":1776919706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425006646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":68,"alternative-id":["S0223523425006646"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117899","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational optimization of D3R\/GSK-3\u03b2 dual target-directed ligands as potential treatment for bipolar disorder: Design, synthesis, X-ray crystallography, molecular dynamics simulations, in vitro ADME, and in vivo pharmacokinetic studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117899"}}